ADMA - ADMA Stock Receives Consensus Buy Rating Major Upswing Ahead?

ADMA stock has just received a consensus rating of “Buy” from nine brokerages covering the stock. With all in agreement, why are analysts bullish on this biotechnology stock?

Let’s find out!

Selling for $4.53 at present on the NASDAQ exchange, ADMA Biologics Inc (NASDAQ:ADMA) has had a tough time crossing the $5 mark. The volatile month shows increasing trading volume, yet investors seem unsure—sudden gains are correcting almost on the daily. But a surge to $5 and above could be on the horizon, as according to Marketbeat, the stock has an average ...